Evidence map›Paper›PMID 35368908›Full record

ArticleiScience2022

Phylogenetic-based inference reveals distinct transmission dynamics of SARS-CoV-2 lineages Gamma and P.2 in Brazil.

Tiago Gräf, Gonzalo Bello, Felipe Gomes Naveca, Marcelo Gomes, Vanessa Leiko Oikawa Cardoso, Alexandre Freitas da Silva, Filipe Zimmer Dezordi, Mirleide Cordeiro Dos Santos, Katia Correa de Oliveira Santos, Érika Lopes Rocha Batista and 10 more

Abstract read
In one paragraph

Article in iScience, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. CD4Frontiers in immunology · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

Tiago GräfInstituto Gonçalo Moniz, Fundação Oswaldo Cruz, Salvador, Brazil.
Gonzalo BelloLaboratório de AIDS e Imunologia Molecular, Instituto Oswaldo Cruz, FIOCRUZ, Rio de Janeiro, Brazil.
Felipe Gomes NavecaLaboratório de Ecologia de Doenças Transmissíveis na Amazônia (EDTA), Leônidas e Maria Deane Institute, Fiocruz, Manaus, Brazil.
Marcelo GomesGrupo de Métodos Analíticos em Vigilância Epidemiológica, Programa de Computação Científica (PROCC), Fiocruz, Rio de Janeiro, Brazil.
Vanessa Leiko Oikawa CardosoInstituto Gonçalo Moniz, Fundação Oswaldo Cruz, Salvador, Brazil.
Alexandre Freitas da SilvaInstituto Aggeu Magalhães, Fundação Oswaldo Cruz, Recife, Pernambuco, Brazil.
Filipe Zimmer DezordiInstituto Aggeu Magalhães, Fundação Oswaldo Cruz, Recife, Pernambuco, Brazil.
Mirleide Cordeiro Dos SantosInstituto Evandro Chagas, Belem, Para, Brazil.
Katia Correa de Oliveira SantosInstituto Adolfo Lutz, São Paulo, Brazil.
Érika Lopes Rocha BatistaSecretaria de Saúde de Aparecida de Goiânia, Goiás, Brazil.
Alessandro Leonardo Álvares MagalhãesSecretaria de Saúde de Aparecida de Goiânia, Goiás, Brazil.
Fernando VinhalLab HLAGYN - Goiânia, Goias, Brazil.
Fábio MiyajimaFundação Oswaldo Cruz - Fiocruz Ceará, Fortaleza, Brazil.
Helisson FaoroInstituto Carlos Chagas (ICC), Fiocruz-PR, Curitiba, Parana, Brazil.
Ricardo KhouriInstituto Gonçalo Moniz, Fundação Oswaldo Cruz, Salvador, Brazil.
Gabriel Luz WallauInstituto Aggeu Magalhães, Fundação Oswaldo Cruz, Recife, Pernambuco, Brazil.
Edson DelatorreDepartamento de Biologia. Centro de Ciencias Exatas, Naturais e da Saude, Universidade Federal do Espirito Santo, Alegre, Brazil.
Marilda Mendonça SiqueiraLaboratory of Respiratory Viruses and Measles, Oswaldo Cruz Institute (IOC), Oswaldo Cruz Foundation (FIOCRUZ), Rio de Janeiro, RJ, Brazil.
Paola Cristina ResendeLaboratory of Respiratory Viruses and Measles, Oswaldo Cruz Institute (IOC), Oswaldo Cruz Foundation (FIOCRUZ), Rio de Janeiro, RJ, Brazil.
Brazilian Ministry of Health COVID-19 Genomic Surveillance Network

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The COVID-19 epidemic in Brazil experienced two major lineage replacements until mid-2021. The first was driven by lineage P.2, in late 2020, and the second by lineage Gamma, in early 2021. To understand how these SARS-CoV-2 lineages spread in Brazil, we analyzed 11,724 genomes collected throughout the country between September 2020 and April 2021. Our findings indicate that lineage P.2 probably emerged in July 2020 in the Rio de Janeiro state and Gamma in November 2020 in the Amazonas state. Both states were the main hubs of viral disseminations to other Brazilian locations. We estimate that Gamma was 1.56-3.06 times more transmissible than P.2 in Rio de Janeiro and that the median effective reproductive number (Re) of Gamma varied according to the geographic context (Re = 1.59-3.55). In summary, our findings support that lineage Gamma was more transmissible and spread faster than P.2 in Brazil.

Indexed as

Biological sciencesPhylogenyviral microbiology

Identifiers

PMID35368908
PMCPMC8957357

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.